Company profile for Adaptam Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Adaptam Therapeutics is pioneering next-generation cancer immunotherapies by targeting the immunosuppressive myeloid tumor microenvironment (TME) through glyco-immune checkpoints. Solid tumors are often dominated by tumor-associated macrophages (TAMs) that drive resistance to current treatments. Adaptam’s discoveries in cancer immunology and glycobiology have uncovered key pathways driving myeloid-mediated immune suppression...
Adaptam Therapeutics is pioneering next-generation cancer immunotherapies by targeting the immunosuppressive myeloid tumor microenvironment (TME) through glyco-immune checkpoints. Solid tumors are often dominated by tumor-associated macrophages (TAMs) that drive resistance to current treatments. Adaptam’s discoveries in cancer immunology and glycobiology have uncovered key pathways driving myeloid-mediated immune suppression. Leveraging in-house antibody discovery, Adaptam develops first-in-class antibodies, ADCs, and bispecifics to reprogram the TME and enhance T cell responses across solid tumors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Gipuzkoa Science and Technology Park Tandem Building / Paseo Miramón 170 2001...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty